Newsroom

Leading inhalation APIs expert Inke to triple production capacity

20 APR

To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs

Read more
Inke to sponsor the virtual Drug Delivery to the Lungs Conference 2021

25 NOV

Inke is sponsoring Drug Delivery to the Lungs (DDL2021) Conference 2021

Read more
Corporate announcement: COVID-19 update

23 MAR

Corporate announcement: Update concerning novel coronavirus (COVID-19)

Read more
Inke to exhibit at the Drug Delivery to the Lungs (DDL) Conference 2019 in Edinburgh

07 DEC

Inke is exhibiting at DDL2019 in Edinburgh, 11th to 13th December, to celebrate 30 years of Drug Delivery to the Lungs (DDL) Conference.

Read more
Inke exhibits at the Inhalation Asia 2019 in Hong Kong

08 NOV

Inke is attending Inhalation Asia 2019 in Hong Kong on the 13th – 15th November. The once every two years exhibition will take place at the Hong Kong Science and Technology Park, in Sha Tin.

Read more

12 3 4